Sally Ibrahim, MD
Sleep Medicine · Cleveland, OHNPI 1215130786
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Avadel CNS Pharmaceuticals, LLC accounts for 74.0% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $5,831, more than ten times the $245 reported in 2019.
Across 45 payments — averaging $169.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avadel CNS Pharmaceuticals, LLC$6K
- Jazz Pharmaceuticals Inc.$1K
- Inspire Medical Systems, Inc.$321
- Harmony Biosciences LLC$239
- Abiomed$137
- Lilly USA, LLC$17
- plus $17 from 1 others
Across 109 payments — averaging $1124.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Harmony Biosciences LLC$64K
- Jazz Pharmaceuticals Inc.$58K
What the payments were for
- Consulting fees$4,36057%
- Travel & lodging$91112%
- Food & beverage$2,16128%
- Education$1902%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 18 | $5,640 |
| Jazz Pharmaceuticals Inc. | 14 | $1,252 |
| Inspire Medical Systems, Inc. | 2 | $321 |
| Harmony Biosciences LLC | 8 | $239 |
| Abiomed | 1 | $137 |
| Lilly USA, LLC | 1 | $17 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,622 in reported general payments places this provider in the 85th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XyremSodium Oxybate | 12 | $253,860 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $222 |
| Gabapentin | 12 | $188 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Cleveland
- Nancy Foldvary-SchaeferCleveland$75K
- Brian ChenCleveland$18K
- Anna MayCleveland$7K
- Vaishal ShahCleveland$5K
- Colleen LanceCleveland$5K
- Eric YehCleveland$4K
- Louis KazaglisCleveland$4K
- Catherine di LisioCleveland$2K
- Ambrose ChiangCleveland$2K
- Jessica Vensel RundoCleveland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.